Formula Growth’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,200
Closed -$180K 139
2025
Q1
$180K Hold
10,200
0.07% 118
2024
Q4
$248K Hold
10,200
0.08% 115
2024
Q3
$379K Hold
10,200
0.13% 105
2024
Q2
$486K Hold
10,200
0.18% 104
2024
Q1
$390K Hold
10,200
0.12% 110
2023
Q4
$318K Hold
10,200
0.1% 126
2023
Q3
$410K Hold
10,200
0.14% 128
2023
Q2
$536K Hold
10,200
0.17% 124
2023
Q1
$652K Hold
10,200
0.21% 115
2022
Q4
$495K Hold
10,200
0.14% 122
2022
Q3
$720K Sell
10,200
-1,800
-15% -$154K 0.21% 107
2022
Q2
$851K Sell
12,000
-6,000
-33% -$387K 0.24% 105
2022
Q1
$1.44M Hold
18,000
0.27% 101
2021
Q4
$1.64M Hold
18,000
0.29% 98
2021
Q3
$2.31M Hold
18,000
0.33% 90
2021
Q2
$2.75M Sell
18,000
-4,000
-18% -$527K 0.38% 85
2021
Q1
$2.32M Hold
22,000
0.33% 90
2020
Q4
$1.74M Sell
22,000
-2,000
-8% -$146K 0.29% 90
2020
Q3
$1.36M Hold
24,000
0.25% 103
2020
Q2
$1.48M Sell
24,000
-6,000
-20% -$245K 0.25% 92
2020
Q1
$968K Hold
30,000
0.19% 97
2019
Q4
$1.05M Hold
30,000
0.13% 115
2019
Q3
$773K Hold
30,000
0.12% 132
2019
Q2
$881K Buy
30,000
+5,000
+20% +$144K 0.13% 130
2019
Q1
$855K Buy
+25,000
New +$885K 0.12% 128

Other funds holding STAA

Formula Growth's STAA Position: Q2 2025 in Review

Formula Growth sold out of STAAR Surgical (STAA) in Q2 2025, closing a stake of 10,200 shares — an estimated $180K sold.

Formula Growth first reported a position in STAA in Q1 2019 and held it in 25 quarters. The position peaked at $2.75M in Q2 2021. 170 funds tracked by Wall St. Rank hold STAA as of Q2 2025.

  • Formula Growth reported no remaining STAAR Surgical position as of Q2 2025 after selling out during the quarter.
  • Formula Growth sold 10,200 STAAR Surgical shares in Q2 2025, an estimated $180K.
  • Formula Growth first reported a position in STAAR Surgical in Q1 2019 and held it in 25 quarters.
  • Formula Growth's STAAR Surgical position peaked at $2.75M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2025.

Based on Formula Growth's 13F filing for Q2 2025, filed 13 Aug 2025.